Last kr264.00 DKK
Change Today +0.40 / 0.15%
Volume 356.5K
As of 11:02 AM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steen Riisgaard

Former Chief Executive Officer and President, Novozymes A/S
AgeTotal Calculated CompensationThis person is connected to 59 board members in 10 different organizations across 10 different industries.

See Board Relationships
63--

Background*

Mr. Steen Riisgaard served as the Chief Executive Officer and President at Novozymes A/S at Sustainable Performance Group AG from 2000 to April 01, 2013. Mr. Riisgaard served as Chief Executive Officer of Novo Nordisk A/S from 1989 to 2000. He served as Director of Detergent Enzyme Division at Novo Industri A/S since 1986 and Enzyme Process Research at Novo Industri A/S since 1985. He served as Corporate Executive Vice President, Enzyme Business, Novo Nordisk A/S, from ...

Read Full Background

Corporate Headquarters*

Krogshoejvej 36
Bagsvaerd, -- 2880

Denmark

Phone: 45 44 46 00 00
Fax: 45 44 46 99 99

Board Members Memberships*

Director
Chairman
Chairman
Director
Chairman of The Board
Deputy Chairman
2002-Present
Chairman
2008-Present
Director and Member of Remuneration Committee
2011-Present
Chairman, Chairman of Remuneration Committee and Member of Audit Committee

Education*

MS 1976
Københavns Universitet

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NZYMB:DC kr264.00 DKK +0.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Rakesh Kapoor Chief Executive Officer, Executive Director and Member of Nomination Committee
Reckitt Benckiser Group plc
4.4M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-B SHARES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.